Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Just caught wind of a pretty rough exit from Pier Capital on Ardent Health stock. They dumped their entire position last quarter, roughly 580k shares for about $7.7 million. What's interesting is the timing here. The fund had Ardent as a solid 1.2% of their AUM before, but clearly something shifted. Looking at the broader picture, Ardent's been getting hammered - down 43% over the past year while the S&P 500 climbed 14%. The stock was trading around $8.59 as of early February. So what spooked them? Q3 actually looked decent on the surface - admissions up 5.8%, revenue jumping nearly 9% year-over-year. But then management cut their adjusted EBITDA guidance to $530-555 million, citing payor denials and cost inflation. That's the kind of thing that tanks confidence fast. The $23 million net loss that quarter probably didn't help either. You can see why a fund would want out of something that complex. Healthcare operators like Ardent deal with regulatory headaches, labor costs, and reimbursement pressure that can squeeze margins hard. Not exactly the cleanest business to own when things tighten up. Their remaining top holdings lean more toward industrials and financials, which tells you something about their risk appetite these days.